| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Coherus Oncology, Inc. (CHRS) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 11 sells. CHRS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 30.0K | $44.4K | - | |
| CFO | 15.0K | $22.2K | - | |
| CEO | 0 | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 18, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sell | 1,388 | $19.02 | $26,399.76 | -17.9% | |
| Oct 16, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,159 | $19.00 | $60,021.00 | -28.9% | |
| Oct 14, 2019 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,500 | $18.40 | $46,000.00 | -11.5% | |
| Sep 23, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sell | 740 | $21.78 | $16,117.20 | -8.7% | |
| Sep 18, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 3,159 | $20.44 | $64,559.85 | -27.1% | |
| Sep 16, 2019 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,500 | $20.03 | $50,075.00 | -11.5% | |
| Aug 21, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sale+OE | 6,318 | $21.71 | $137,154.42 | -21.5% | |
| Aug 19, 2019 | Viret Jean-Frederic | Chief Financial Officer | Sell | 3,000 | $19.04 | $57,120.00 | -26.1% | |
| Aug 14, 2019 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,500 | $19.00 | $47,500.00 | -11.5% | |
| Jul 15, 2019 | Anicetti Vincent R | Chief Operating Officer | Sale+OE | 2,500 | $19.20 | $48,000.00 | -11.5% |